RheumaGen

Aurora, United States

RheumaGen develops a class of cell and gene therapy treatments aimed at autoimmune diseases.

Dec 2025

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are RheumaGen's investors?

RheumaGen's investors include SPRIM Global Investments, Beyond Celiac Investments, William Taylor Nominees.

Where is RheumaGen headquartered?

RheumaGen is headquartered in Aurora, United States.

What does RheumaGen do?

RheumaGen develops a class of cell and gene therapy treatments aimed at autoimmune diseases.

What stage is RheumaGen at?

RheumaGen is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 22, 2025.

MLA

"RheumaGen — Funding & Investors." VCBacked, December 22, 2025, https://www.vcbacked.co/company/rheumagen. Accessed July 2, 2026.

APA

VCBacked. (2025). RheumaGen — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/rheumagen

Wikipedia (cite web)

{{cite web |title=RheumaGen — Funding & Investors |url=https://www.vcbacked.co/company/rheumagen |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 22, 2025.